(1)
Longitudinal Monitoring of Apparent Diffusion Coefficient (ADC) In Patients With Prostate Cancer Undergoing MR-Guided Radiotherapy on an MR-Linac at 1.5 T: A Prospective Feasibility Study. Radiol Oncol 2023, 57 (2), 184-190.